1644.0000 -12.00 (-0.72%)
NSE Sep 22, 2025 15:31 PM
Volume: 1.8M
 

1644.00
-0.72%
BOB Capital Markets Ltd.
Sun Pharma (SUNP) and Hikma today entered into an exclusive licensing and distribution agreement for Ilumya for the MENA region.
Sun Pharmaceutical I.. has an average target of 2050.25 from 8 brokers.
More from Sun Pharmaceutical Industries Ltd.
Recommended